|
|
Industry Trends |
 |
Pharm Exec’s Industry Audit 2019 |
Pharm Exec’s latest analysis of financial performance reveals that it’s those drugmakers maximizing the difference between the value and the cost of their capital investments that are delivering the most bang for the buck to shareholders
… /Read more/ |
|
|
|
Interview |
 |
|
|
|
Calendar |
/ October 21–22: Real-World Data and Evidence Summit / |
Arlington, VA |
/ October 21–22: Life Sciences Value-Based Contracting / |
Arlington, VA |
/ October 28–29: 5th Annual Bio/Pharmaceutical Product Launch Summit / |
Boston, MA |
/ November 13–14: 6th Annual Global Compliance Congress / |
London, UK |
/ November 19–21: Clinical Supply Chain Europe / |
Barcelona, Spain |
/ December 11: eyeforpharma Awards 2019 / |
Philadelphia, PA |
/ December 11¬–12: Pharmaceutical Drug Pricing Strategies Summit / |
Washington, DC |
/ December 11: Clinical Trial Financial Management / |
Philadelphia, PA |
/ February 27–28: Pharmaceutical Compliance Congress Asia / |
Kyoto, Japan |
/ March 18–19 2020: World Pharma Pricing Market Access & Evidence Congress / |
Amsterdam, The Netherlands |
|
|
Industry update |
// Cerecin (Singapore) appointed Lilian Chow as Vice President, Clinical Operations and Regulatory Affairs.
// GENFIT (Lille, France and Cambridge, MA) named Dr. Dean Hum as President and Dr. Suneil Hosmane as Head of Global Diagnostics.
// Keith Thompson, Chief Executive Officer of the Cell and Gene Therapy Catapult (London, UK) has announced he will retire in April 2020.
// Ophthalmic therapy company SIFI (Catania, Sicily) appointed Fabrizio Folco as Country Manager, Italy.
// Vifor Pharma (St Gallen, Switzerland) announced that Dr. Klaus Henning Jensen will join the company as Chief Medical Officer and member of the Executive Committee in January 2020. Dario Eklund, Chief Commercial Officer left the company at the end of September. A search for a successor is underway, the company reports.
|
|
|
|
|
|